CLINICAL AND MICROBIOLOGICAL PROFILE OF SECONDARY BLOODSTREAM INFECTIONS RESULTING FROM URINARY TRACT INFECTION CAUSED BY ENTEROBACTERALES

NANDHINI S; ARUNAVA KALI; VALENTINA Y; PRAVIN CHARLES M.V; JOSHY M EASOW

doi:10.22159/ajpcr.2025v18i2.53668

Authors

NANDHINI S Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed-to-be-University, Puducherry, India.
ARUNAVA KALI Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed-to-be-University, Puducherry, India.
VALENTINA Y Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed-to-be-University, Puducherry, India
PRAVIN CHARLES M.V Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed-to-be-University, Puducherry, India.
JOSHY M EASOW Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth Deemed-to-be-University, Puducherry, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i2.53668

Keywords:

Secondary Blood Stream Infections, Urinary Tract Infection, Enterobacterales, Multi-drug resistance

Abstract

Objectives: Bloodstream infection (BSI) is a common sequelae of urinary tract infections (UTIs) and it requires early detection and appropriate antibiotic therapy. This study analyzed the clinical and microbiological profile of secondary BSI resulting from UTI caused by Enterobacterales.

Methods: In this retrospective study, National Healthcare Safety Network criteria were used to define the cases of UTI and secondary BSI attributed to UTI. Data from medical records and laboratory reports of patients from January to May 2024 were compiled and analyzed.

Results: Among 932 urine samples with significant growth of Enterobacterales, 48 were blood cultures positive. Out of them, 26 patients (11 males and 15 females) met the criteria of BSI secondary to UTI as the same isolates also grew in blood specimens which was taken within the secondary BSI attribution period. Nine patients had catheter-associated symptomatic UTI (CA-SUTI) while 14 were non-CA-SUTI and 3 had asymptomatic bacteriuria. In urine culture, Escherichia coli (n=22, 68.1% multi-drug resistant and 31.8% non-multi-drug resistant [MDR]), Klebsiella pneumoniae (n=3, all MDR), and Citrobacter koseri (n=1, non-MDR) strains were isolated. Diabetes, renal calculi, fever, Foley’s catheter, age >60 years, intensive care unit admission, and hospital stay >10 days were more among individuals with MDR infections. Cefoperazone-sulbactam, piperacillin/tazobactam, and nitrofurantoin had good outcomes.

Conclusion: Cefoperazone-sulbactam, piperacillin/tazobactam, and nitrofurantoin were effective for treating patients with BSI attributed to UTI in our hospital with good outcomes. Hence, these antibiotics might have a critical role as empirical therapy for such, particularly those with underlying health conditions and risk factors for MDR infections.

Downloads

Download data is not yet available.

References

Al-Hasan MN, Eckel-Passow JE, Baddour LM. Bacteremia complicating gram-negative urinary tract infections: A population-based study. J Infect. 2010;60(4):278-85. doi: 10.1016/j.jinf.2010.01.007, PMID 20114061

Gómez-Zorrilla S, Becerra-Aparicio F, López Montesinos I, Ruiz de Gopegui E, Grau I, Pintado V, et al. A large multicenter prospective study of community-onset healthcare associated bacteremic urinary tract infections in the era of multidrug resistance: Even worse than hospital acquired infections? Infect Dis Ther. 2021;10(4):2677-99. doi: 10.1007/s40121-021-00537-0, PMID 34626347

Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007;26(5):349-52. doi: 10.1007/s10096-007-0287-3, PMID 17431694

Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Tate ME, et al. Antibiotic de-escalation in bacteremic urinary tract infections: Potential opportunities and effect on outcome. Infection. 2014;42(5):829-34. doi: 10.1007/s15010-014-0639-8, PMID 24874607

Chin BS, Kim MS, Han SH, Shin SY, Choi HK, Chae YT, et al. Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients. Arch Gerontol Geriatr. 2011;52(1):e50-5. doi: 10.1016/j.archger.2010.05.011, PMID 20579748

Ranjini CY, Kasukurthi LR, Madhumati B, Rajendran R. Prevalence of multidrug resistance and extended spectrum beta-lactamases among uropathogenic Escherichia coli isolates in a tertiary care hospital in South India: An alarming trend. Community Acquir Infect. 2015;2:19-24.

National Healthcare Safety Network (NHSN) Patient Safety Component Manual. Centers for Disease Control and Prevention; 2024. Available from: https://www.cdc.gov/nhsn/pdfs/pscmanual/pcsmanual_current. pdf

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x, PMID 21793988 9. Choi MH, Kim D, Park Y, Jeong SH. Impact of urinary tract infection-causative microorganisms on the progression to bloodstream infection: A propensity score-matched analysis. J Infect. 2022;85(5):513-8. doi: 10.1016/j.jinf.2022.08.039, PMID 36064046

Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, et al. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: A prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect. 2013;19(10):962-8. doi: 10.1111/1469-0691.12089, PMID 23279375

Wagenlehner FM, Pilatz A, Weidner W, Naber KG. Urosepsis: Overview of the diagnostic and treatment challenges. Microbiol Spectr. 2015;3(5): 27864665

Brindha SG, Hansiya V, Maheswari PU, Geetha N. A comparative in vitro anti-biofilm efficacy of phytosynthesized iron and silver nanoparticles. Int J App Pharm. 2020;12:72-6.

Rosenthal EJ. Epidemiology of septicaemia pathogens. Dtsch Med Wochenschr. 2002;127(46):2435-40. doi: 10.1055/s-2002-35463, PMID 12432483

Lee YC, Hsiao CY, Hung MC, Hung SC, Wang HP, Huang YJ, et al. Bacteremic urinary tract infection caused by multidrug-resistant Enterobacteriaceae Are associated with severe sepsis at admission: Implication for empirical therapy. Med (Baltim). 2016;95(20):e3694. doi: 10.1097/MD.0000000000003694, PMID 27196480

Lam PW, Wiggers JB, Lo J, MacFadden DR, Daneman N. Utility of urine cultures in predicting blood culture susceptibilities in patients with bacteremic urinary tract infection. Antimicrob Agents Chemother. 2019;63(1):e01606-18. doi: 10.1128/AAC.01606-18, PMID 30323048

Gómez-Zorrilla S, Becerra-Aparicio F, Sendra E, Zamorano L, Grau I, Pintado V, et al. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteremic urinary tract infections: A post-hoc analysis of a multicenter prospective cohort in Spain. J Hosp Infect. 2024;151:173-85. doi: 10.1016/j.jhin.2024.05.020

Shareef A, Vasavan A, Roy A, James AJ, Nair CC, Aiswarya S. Antibiotic de-escalation in bacteremic UTI and its impact on cost and length of stay-a prospective observational study in a tertiary care teaching hospital in south Kerala. Int J Pharm Sci Res. 2023;14(9):4572-79.

Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, et al. Effectiveness of fosfomycin for the treatment of multidrug-resistant Escherichia coli bacteremic urinary tract infections: A randomized clinical trial. JAMA Netw Open. 2022;5(1):e2137277. doi: 10.1001/ jamanetworkopen.2021.37277, PMID 35024838 doi: 10.1128/microbiolspec.UTI-0003-2012, PMID 26542042

Harikrishnan S, Vennila R, Monica R. Isolation and characterisation of anti-bacterial resistance patterns of bacterial isolates from urinary tract infection in diabetics. Int J Curr Pharm Res. 2021;13(1):57-59.

Sarkar S, Sadhu S, Roy R, Tarafdar S, Mukherjee N, Sil M, et al. Contemporary drifts in diabetes management. Int J App Pharm. 2023;15(2):1-9.

Varma M, Peravali SK, Vandana K, Kamath A, Singh RJ. A study of risk factors for bacteremia caused by urinary tract infections. Asian J Med Sci. 2018;9(5):25-30.

Shaw E, Benito N, Rodríguez-Baño J, Padilla B, Pintado V, Calbo E, et al. Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort. J Infect. 2015;70(3):247-54. doi: 10.1016/j. jinf.2014.09.011, PMID 25305497

Lalueza A, Sanz-Trepiana L, Bermejo N, Yaiza B, Morales- Cartagena A, Espinosa M, et al. Risk factors for bacteremia in urinary tract infections attended in the emergency department. Intern Emerg Med. 2018;13(1):41-50. doi: 10.1007/s11739-016-1576-6, PMID